Fennec Pharmaceuticals, Inc. (FRX.TO)
11.65
0.00 (0.00%)
CAD |
TSX |
Feb 27, 16:00
Fennec Pharmaceuticals Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.175M |
| Cash from Financing (Quarterly) | 2.445M |
| Free Cash Flow | -10.80M |
| Free Cash Flow Per Share (Quarterly) | 0.078 |
| Free Cash Flow to Equity (Quarterly) | 1.67M |
| Free Cash Flow to Firm (Quarterly) | 2.998M |
| Free Cash Flow Yield | -3.35% |